![Russell Clayton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Russell Clayton
Chief Tech/Sci/R&D Officer at
LARIMAR THERAPEUTICS, INC.
Net worth: 248 622 $ as of 31/05/2026
Profile
Russell G.
Clayton is currently Chief Medical Officer at Larimar Therapeutics, Inc. since 2023.
Former positions include Regional Medical Director-Scientific Affairs at Merck & Co., Inc., Director-Asthma Program Division at The Children's Hospital of Philadelphia Foundation, Chief Medical Officer at Alcresta Therapeutics, Inc. from 2015 to 2017, and Senior Vice President-Research & Development at Windtree Therapeutics, Inc. from 2011 to 2014.
Education includes undergraduate studies at LaSalle University and a doctorate from Philadelphia College of Osteopathic Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/01/2026 | 71,443 ( 0.08% ) | 248 622 $ | 31/05/2026 |
Russell Clayton active positions
| Companies | Position | Start |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 17/07/2023 |
Former positions of Russell Clayton
| Companies | Position | End |
|---|---|---|
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Chief Tech/Sci/R&D Officer | 01/04/2017 |
| WINDTREE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2014 |
The Children's Hospital of Philadelphia Foundation
 The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services Provides health care services | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | - |
Training of Russell Clayton
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
26
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Windtree Therapeutics, Inc.
 Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
LaSalle University
 LaSalle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Hospital of Philadelphia Foundation
The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Philadelphia College of Osteopathic Medicine
 Philadelphia College of Osteopathic Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Health Technology |
Larimar Therapeutics, Inc.
 Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
- Stock Market
- Insiders
- Russell Clayton
